USP 665 and 1665 Extractables for Components in Pharmaceutical and Biopharmaceutical Manufacturing
46:14
Toxicological Safety Assessment of Process Equipment-Related Leachables in the context of USP (665)
20:29
USP (665) survey – insights and results
55:57
Discoveries on Applying the New ISO 10993 17
25:38
Qualification of Single Use Materials for Biopharmaceutical Manufacturing
35:50
USP (665) Focus on Component Qualification – What About Component Selection?
55:54
Addressing Nitrosamines in APIs and Drugs: Analytical Strategies
26:11
Challenge for Industry with new USP (665) / (1665)
31:55